About IMCI Pharmaceuticals
Who We Are?
IMCI is a pharmaceutical company that develops cannabis-based medicines to treat chronic indications with a global reach.
IMCI R&D is based in Israel with its primary operations being conducted in the USA, Europe, and Israel.
IMCI is operating in the high-end of the pharmaceutical supply chain based upon a unique combination between Israeli leading research institutions together with its team members who possess a proven track record with cannabinoids R&D.
To become a leading pharmaceutical company, who will develop pharmaceutical and medicinal cannabis-based novel medicines to treat prevalent health conditions at an affordable price.
We are open for business
We partner with other companies to co-commercialization products to new indications
We are looking to work with local distributors that hold all the required licenses to distribute the products to pharmacies.